← Feed

Burnett Patrick

SEC Form 4 insider
See Remarks · Arcutis Biotherapeutics, Inc. ($ARQT)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ARQTSEC Form 4bearish
Burnett Patrick · See Remarks at Arcutis Biotherapeutics, Inc. · 4h agono track record yet
Sold 15,000 @ $26.33 avg · $394,897 · 2026-08-11

Form 4: Burnett Patrick sold ARQT

Burnett Patrick (See Remarks at Arcutis Biotherapeutics, Inc.) reported an open-market sale of 15,000 shares of ARQT at an average $26.33, roughly $394,897, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

End of results.